| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/20/2006 | US20060083695 preventing the decomposition of monatin from exposure to ultraviolet light; preserving monatin in a stable state under acidic conditions; use in food, a beverage, a mouth cavity composition, and a pharmaceutical product |
| 04/20/2006 | US20060083694 Multi-component particles comprising inorganic nanoparticles distributed in an organic matrix and processes for making and using same |
| 04/20/2006 | US20060083693 Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| 04/20/2006 | US20060083692 Combination of formoterol and a tiotropium salt |
| 04/20/2006 | US20060083691 Intranasal opioid compositions, delivery devices and methods of using same |
| 04/20/2006 | US20060083690 Less abusable pharmaceutical preparations |
| 04/20/2006 | DE202005004706U1 Composition, useful for peroral application with direct release of active substances, comprises multiplicity and/or a combination of active substances (preferably e.g. vitamins) that are incorporated or stored in a swellable matrix |
| 04/20/2006 | DE102004049822A1 Edible medicine capsule (which opens and closes in air tight and damp proof manner), dependent on animal's size and taste, comprises an internal cavity |
| 04/20/2006 | DE102004049740A1 Selbstklebende Zahnfolie Self-adhesive dental film |
| 04/20/2006 | DE10127897B4 Manteltablette mit Pflanzentrockenextrakten Coated tablet with dry plant extracts |
| 04/20/2006 | CA2583794A1 Compositions for intranasal administration |
| 04/20/2006 | CA2583562A1 Medicament and system for the percutaneous administration of medicaments |
| 04/20/2006 | CA2583561A1 Biocompatible protein particles, particle devices and methods thereof |
| 04/20/2006 | CA2583341A1 Method of formation of the shape-retentive aggregates of gel particles and their uses |
| 04/20/2006 | CA2583323A1 Segmented device for the delayed release of molecules in a tangential direction through thin films and applications thereof |
| 04/20/2006 | CA2583142A1 Method of providing lubricious surfaces |
| 04/20/2006 | CA2583101A1 Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline |
| 04/20/2006 | CA2582242A1 Method of insertion of a lipid-linked moiety into a pre-formed lipid assembly using microwaves |
| 04/20/2006 | CA2581999A1 Preparation of suspension aerosol formulations |
| 04/20/2006 | CA2581605A1 Enteral nutrient |
| 04/20/2006 | CA2581493A1 Taste-masking pharmaceutical compositions |
| 04/20/2006 | CA2580268A1 Large-scale manufacturing process for the production of pharmaceutical compositions |
| 04/20/2006 | CA2578447A1 Bilayer tablet |
| 04/20/2006 | CA2568180A1 Medical solution, method for producing and use thereof |
| 04/20/2006 | CA2566354A1 A mixture for transdermal delivery of low and high molecular weight compounds |
| 04/19/2006 | EP1647494A2 Injection moulded water-soluble container |
| 04/19/2006 | EP1647326A2 Process for preparing capsules having a polyelectrolyte shell |
| 04/19/2006 | EP1647287A2 Drug release stent coating process |
| 04/19/2006 | EP1647277A1 Glycoside-containing liposome |
| 04/19/2006 | EP1647275A1 Solid pharmaceutical preparation |
| 04/19/2006 | EP1647274A1 Remedy for pruritus comprising piperidine derivative as the active ingredient |
| 04/19/2006 | EP1647273A1 Ophthalmic composition |
| 04/19/2006 | EP1647271A1 4-Hydroxy tamoxifen gel formulations |
| 04/19/2006 | EP1647270A2 Process for applying several layers of coating substances to template particles |
| 04/19/2006 | EP1647269A1 Matrix adjuvants and the drop pills prepared with them |
| 04/19/2006 | EP1646445A2 Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation |
| 04/19/2006 | EP1646427A1 Cpg-packaged liposomes |
| 04/19/2006 | EP1646405A1 Pharmaceutical compositions comprising peranhydrocyclodextrin |
| 04/19/2006 | EP1646404A1 Solid composition comprising a proton pump inhibitor |
| 04/19/2006 | EP1646403A2 Pharmaceutical composition for solubility enhancement of hydrophobic drugs |
| 04/19/2006 | EP1646393A1 A stable clozapine suspension formulation |
| 04/19/2006 | EP1646379A2 Novel solid pharmaceutical composition comprising amisulpride |
| 04/19/2006 | EP1646378A1 Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences |
| 04/19/2006 | EP1646374A1 Extended-release tablets of metformin |
| 04/19/2006 | EP1646373A2 Orodispersible pharmaceutical composition of an antithrombotic compound |
| 04/19/2006 | EP1646370A1 Pharmaceutical formulations |
| 04/19/2006 | EP1646369A2 Saquinavir mesylate oral dosage form |
| 04/19/2006 | EP1646368A1 Dual drug dosage forms with improved separation of drugs |
| 04/19/2006 | EP1646367A2 Gellan gum based oral controlled release dosage forms- a novel platform technology for gastric retention |
| 04/19/2006 | EP1646366A1 Method of preparing mixed formulation of sustained release microspheres by continuous one-step process |
| 04/19/2006 | EP1646365A1 Powdery formulations for inhalation, containing a novel anticholinergic agent |
| 04/19/2006 | EP1646364A1 Hfc solution formulations containing an anticholinergic |
| 04/19/2006 | EP1646363A1 Intravaginal drug delivery devices |
| 04/19/2006 | EP1646355A2 Pharmaceutical formulations |
| 04/19/2006 | EP1646354A2 Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof |
| 04/19/2006 | EP1646328A2 Treatment of dependence withdrawal |
| 04/19/2006 | EP1585483A4 Topical stabilized prostaglandin e compound dosage forms |
| 04/19/2006 | EP1562573B1 Pharmaceutical pellets comprising tamsulosin and a process for making the same |
| 04/19/2006 | EP1492569A4 Aqueous dispersible steryl ester compositions |
| 04/19/2006 | EP1436057B1 Rotor-stator apparatus and process for the formation of particles |
| 04/19/2006 | EP1401563B1 Process for the production of micro and/or nano particles |
| 04/19/2006 | EP1368016B1 Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt |
| 04/19/2006 | EP1301175B1 Suppository and composition comprising at least one polyethylene glycol |
| 04/19/2006 | EP1282362B1 Food for slowing down feed intake speed in dogs |
| 04/19/2006 | EP1276495B1 Use of recombinant pulmonary surfactant for the early treatment of acute pulmonary diseases |
| 04/19/2006 | EP1250350B1 Novel crystalline composites comprising phytosterols and phytostanols or derivatives thereof |
| 04/19/2006 | EP1239857B1 Dual-release compositions of a cyclooxygenase-2- inhibitor |
| 04/19/2006 | EP1239849B1 Pharmaceutical formulations comprising resveratrol and use thereof |
| 04/19/2006 | EP1235560B1 Microchip devices for delivery of molecules and methods of fabrication thereof |
| 04/19/2006 | EP1228199B1 Method for directed packaging of molecular substances in protein shells |
| 04/19/2006 | EP1151102B1 Glycosylated leptin compositions and related methods |
| 04/19/2006 | EP1143940B1 Compositions and methods for mucosal delivery |
| 04/19/2006 | EP1143806B1 Method for increasing pet activity |
| 04/19/2006 | EP1126853B1 Controlled delivery of antidepressants |
| 04/19/2006 | EP1107772B1 Composition with bacillus coagulans and use thereof |
| 04/19/2006 | EP1100820B1 Pectic substance as a growth factor stabilizer |
| 04/19/2006 | EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants |
| 04/19/2006 | EP1041987B1 Pharmaceutical oral dosage form comprising a combination of an opioid agonist and naltrexone |
| 04/19/2006 | EP1003479B1 Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 04/19/2006 | EP1001748B1 A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets |
| 04/19/2006 | EP0946143B1 A nitroimidazole gel composition |
| 04/19/2006 | EP0789574B1 Use of naked polynucleotides in the manufacture of a medicament for treating tumours |
| 04/19/2006 | CN1762000A Production of nanoparticulate thin films |
| 04/19/2006 | CN1761661A Pharmaceutical preparations containing arginine amides |
| 04/19/2006 | CN1761486A Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 04/19/2006 | CN1761477A Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 04/19/2006 | CN1761469A Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| 04/19/2006 | CN1761465A Method for manufacturing coated formulation |
| 04/19/2006 | CN1761462A Patch containing nonsteroidal antiinflammatory and analgesic agent |
| 04/19/2006 | CN1761461A Compositions and methods for treatment of premature ejaculation |
| 04/19/2006 | CN1761458A Confectionery products for delivery of pharmaceutically active agents to the throat |
| 04/19/2006 | CN1761457A Amoxicillin trihydrate |
| 04/19/2006 | CN1761456A Crystalline amoxicillin trihydrate powder |
| 04/19/2006 | CN1761455A Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants |
| 04/19/2006 | CN1761454A Method for preparing small particles |
| 04/19/2006 | CN1761453A Controlled release-drug delivery system for oral administration |
| 04/19/2006 | CN1761452A Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 04/19/2006 | CN1761450A Skin preparation for external use characterized by containing sugar derivative of a,a-trehalose |
| 04/19/2006 | CN1760183A New brand of Aripipazole, and preparation method |
| 04/19/2006 | CN1759887A Mucous membrane absorption ingestion type medicinal composition for drawing out interferon, and preparation |